...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Clinicaltrials.gov
5
May 13, 2018 12:58PM

looks like Zenith results so far a good enough for extending the trial... as for money we still have not heard a beep about that eminent PP from last October is a deal in the works with Zenith or just the common DM delays on a financing .... hmm i hope i am wrong on a delay but have yet to be surprised from DMĀ 

4
May 13, 2018 05:19PM
Share
New Message
Please login to post a reply